Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Allergan v. Staar Surgical

This article was originally published in The Gray Sheet

Executive Summary

Allergan v. Staar Surgical: Companies settle November 1992 patent infringement suit filed by Allergan Medical Optics and Microtech against Staar over the companies' intraocular lens insertion technology. Filed in U.S. District Court, the suit alleged that Staar infringed Microtech's U.S. patent No. 4,681,10, which covers the "Bartell Shooter" instrument and a method for inserting intraocular lenses into the eye during cataract surgical procedures. Microtech, which exclusively licenses the patent to Allergan, says in a Sept. 12 release that Staar has "signed a final consent judgment and received a license to the Bartell patent on terms that were not disclosed"...

You may also be interested in...

Germany Approves Unified Patent Court Ratification Bill

The German Bundestag has adopted the Unified Patent Court’s draft ratification bill with the necessary qualified majority.

IHP Launches Funding Campaign

UK-based charity International Health Partners has launched a fresh appeal to double the value funds being raised to send essential medicines to expectant mothers and children at risk of death in areas of extreme deprivation.

Pfizer And Moderna Under Pressure To Agree Vaccine Supplies For Developing Nations

As the first emergency use authorization is granted, Pfizer and Moderna stand accused of neglecting poorer nations as wealthy countries snap up early access to COVID-19 vaccines.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts